Cite
Gabriel AS, Ahnve S, Gnarpe H, et al. Azithromycin therapy in patients with chronic Chlamydia pneumoniae infection and coronary heart disease: immediate and long-term effects on inflammation, coagulation, and lipid status in a double-blind, placebo-controlled study. Eur J Intern Med. 2003;14(8):470-478doi: 10.1016/j.ejim.2003.07.001.
Gabriel, A. S., Ahnve, S., Gnarpe, H., Gnarpe, J., & Martinsson, A. (2003). Azithromycin therapy in patients with chronic Chlamydia pneumoniae infection and coronary heart disease: immediate and long-term effects on inflammation, coagulation, and lipid status in a double-blind, placebo-controlled study. European journal of internal medicine, 14(8), 470-478. https://doi.org/10.1016/j.ejim.2003.07.001
Gabriel, Amon S., et al. "Azithromycin therapy in patients with chronic Chlamydia pneumoniae infection and coronary heart disease: immediate and long-term effects on inflammation, coagulation, and lipid status in a double-blind, placebo-controlled study." European journal of internal medicine vol. 14,8 (2003): 470-478. doi: https://doi.org/10.1016/j.ejim.2003.07.001
Gabriel AS, Ahnve S, Gnarpe H, Gnarpe J, Martinsson A. Azithromycin therapy in patients with chronic Chlamydia pneumoniae infection and coronary heart disease: immediate and long-term effects on inflammation, coagulation, and lipid status in a double-blind, placebo-controlled study. Eur J Intern Med. 2003 Dec;14(8):470-478. doi: 10.1016/j.ejim.2003.07.001. PMID: 14962698.
Copy
Download .nbib